We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Impact of Hospitalization on Ambulatory Blood Pressure and Intraocular Pressure

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01029860
Recruitment Status : Completed
First Posted : December 10, 2009
Last Update Posted : December 17, 2009
Sponsor:
Information provided by:
Aristotle University Of Thessaloniki

Brief Summary:
The purpose of this study is to assess the effect of hospital admission on 24-hour ambulatory blood pressure (ABP) in hypertensive subjects.Treated or untreated hypertensive adults with open angle glaucoma underwent in-hospital and outpatient 24-hour ABP monitoring, in random order 4 weeks apart.

Condition or disease
Blood Pressure

Study Type : Observational
Actual Enrollment : 40 participants
Observational Model: Case-Crossover
Time Perspective: Prospective
Official Title: A Study Investigating the Impact of Hospitalization on Ambulatory Blood Pressure and Intraocular Pressure in Subjects With Mild to Moderate Arterial Hypertension and Untreated Ocular Hypertension
Study Start Date : March 2007
Primary Completion Date : January 2009
Study Completion Date : March 2009




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   30 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Subjects with untreated ocular hypertension and stage 1 arterial hypertension with or without treatment with anti-hypertensive agents.
Criteria

Inclusion Criteria:

  • age >30 years old.
  • subject has signed an informed consent.
  • patient has untreated ocular hypertension (IOP at 10:00 between 22-34 mm Hg)
  • patient has stage 1 arterial hypertension with or without therapy

Exclusion Criteria:

  • secondary hypertension.
  • stage 2 or 3 hypertension, history of renal disease.
  • sleep apnea.
  • diabetes mellitus
  • acute or chronic inflammation.
  • myocardial infarction or unstable angina within the past 6 months.
  • heart failure NYHA class III-IV.
  • active liver disease.
  • pregnancy.
  • history of drug or alcohol abuse, or any other condition with poor prognosis.
  • treatment with non-steroid anti-inflammatory agents, corticosteroids, beta-blockers, or any other regimen that could affect BP levels.
  • smoking

Responsible Party: Anastasios Lasaridis, 1st Department of Internal Medicine, Aristotle University, Thessaloniki
ClinicalTrials.gov Identifier: NCT01029860     History of Changes
Other Study ID Numbers: A3244
First Posted: December 10, 2009    Key Record Dates
Last Update Posted: December 17, 2009
Last Verified: March 2007

Keywords provided by Aristotle University Of Thessaloniki:
Hypertension
Ambulatory measurement